canagliflozin
Showing 26 - 49 of 49
Type 2 Diabetes, Overweight, Obesity Trial in Boston (Canagliflozin, Placebo)
Completed
- Type 2 Diabetes
- +2 more
- Canagliflozin
- Placebo
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 2, 2018
Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Diabetic Nephropathy
- Canagliflozin
- Placebo
-
Birmingham, Alabama
- +592 more
Dec 4, 2019
Participants With Type 2 Diabetes Mellitus (T2DM)
Completed
- Diabetes Mellitus, Type 2
- Canagliflozin
- +7 more
-
Trevose, PennsylvaniaHealth ResearchTx, LLC
Nov 17, 2017
Healthy Trial in Lincoln (Canagliflozin and Metformin Extended Release (XR) Fixed Dose Combination [FDC], Canagliflozin,
Completed
- Healthy
- Canagliflozin and Metformin Extended Release (XR) Fixed Dose Combination [FDC]
- +2 more
-
Lincoln, Nebraska(unnamed)
Mar 1, 2017
Diabetes, Obesity Trial in Boston (Canagliflozin)
Withdrawn
- Diabetes, Obesity
- Canagliflozin
-
Boston, MassachusettsJoslin Diabetes Center
Feb 28, 2017
Healthy Trial in Tempe (Canagliflozin and Metformin Extended Release (XR) Fixed Dose Combination [FDC], Canagliflozin, Metformin
Completed
- Healthy
- Canagliflozin and Metformin Extended Release (XR) Fixed Dose Combination [FDC]
- +2 more
-
Tempe, Arizona(unnamed)
Feb 8, 2017
Healthy Trial in Tempe (Canagliflozin and Metformin Extended Release (XR) Fixed Dose Combination [FDC], Canagliflozin, Metformin
Completed
- Healthy
- Canagliflozin and Metformin Extended Release (XR) Fixed Dose Combination [FDC]
- +2 more
-
Tempe, Arizona(unnamed)
Dec 1, 2016
Diabetes, Type 2, Hypertension Trial in Puerto Rico, United States (Canagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Hypertension
- Canagliflozin
- Placebo
-
Birmingham, Alabama
- +56 more
Mar 2, 2017
Diabetes, Type 2 Trial in Worldwide (Canagliflozin, Placebo, Sitagliptin)
Completed
- Diabetes Mellitus, Type 2
- Canagliflozin
- +2 more
-
Phoenix, Arizona
- +78 more
Feb 15, 2017
Bioequivalence Trial in Lincoln (Canagliflozin and Metformin Immediate Release (IR) Fixed Dose Combination [FDC], Canagliflozin,
Completed
- Bioequivalence
- Canagliflozin and Metformin Immediate Release (IR) Fixed Dose Combination [FDC]
- +2 more
-
Lincoln, Nebraska(unnamed)
Nov 24, 2014
Healthy Trial in Lincoln (Canagliflozin + Metformin Immediate Release (IR) Fixed Dose Combination (FDC), Canagliflozin,
Completed
- Healthy
- Canagliflozin + Metformin Immediate Release (IR) Fixed Dose Combination (FDC)
- +2 more
-
Lincoln, Nebraska(unnamed)
Nov 18, 2014
Diabetes, Type 2, Plasma Volume Trial in Neuss (Canagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Plasma Volume
- Canagliflozin
- Placebo
-
Neuss, Germany(unnamed)
Aug 19, 2014
Healthy Trial in Merksem (Canagliflozin)
Completed
- Healthy
- Canagliflozin
-
Merksem, Belgium(unnamed)
Apr 7, 2014
Healthy, Hepatic Insufficiency Trial in Orlando, Knoxville (Canagliflozin)
Completed
- Healthy
- Hepatic Insufficiency
- Canagliflozin
-
Orlando, Florida
- +1 more
May 27, 2013
Diabetes, Type 2, Renal Insufficiency Trial in Worldwide (Canagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Renal Insufficiency
- Canagliflozin
- Placebo
-
Concord, California
- +108 more
Aug 2, 2013
Diabetes, Type 2 Trial in Worldwide (Placebo, Canagliflozin, Sitagliptin)
Completed
- Diabetes Mellitus, Type 2
- Placebo
- +4 more
-
Anniston, Alabama
- +82 more
Jun 26, 2013
Diabetes, Type 2 Trial in Worldwide (Placebo, Canagliflozin, Sitagliptin)
Completed
- Diabetes Mellitus, Type 2
- Placebo
- +3 more
-
Little Rock, Arkansas
- +127 more
Jul 25, 2013
Diabetes, Type 2 Trial in Worldwide (Canagliflozin, Placebo, Metformin)
Completed
- Diabetes Mellitus, Type 2
- Canagliflozin
- +3 more
-
Huntsville, Alabama
- +75 more
Jun 12, 2013
Diabetes, Type 2 Trial in Neuss (Canagliflozin)
Completed
- Diabetes Mellitus, Type 2
- Canagliflozin
-
Neuss, Germany(unnamed)
Apr 19, 2013
Healthy Trial (Canagliflozin)
Completed
- Healthy
- Canagliflozin
- (no location specified)
Sep 29, 2012